Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005

Abstract Objective To provide current global and regional estimates of anaemia prevalence and number of persons affected in the total population and by population subgroup. Setting and design We used anaemia prevalence data from the WHO Vitamin and Mineral Nutrition Information System for 1993-2005 to generate anaemia prevalence estimates for countries with data representative at the national level or at the first administrative level that is below the national level. For countries without eligible data, we employed regression-based estimates, which used the UN Human Development Index (HDI) and other health indicators. We combined country estimates, weighted by their population, to estimate anaemia prevalence at the global level, by UN Regions and by category of human development. Results Survey data covered 48·8 % of the global population, 76·1 % of preschool-aged children, 69·0 % of pregnant women and 73·5 % of non-pregnant women. The estimated global anaemia prevalence is 24·8 % (95 % CI 22·9, 26·7 %), affecting 1·62 billion people (95 % CI 1·50, 1·74 billion). Estimated anaemia prevalence is 47·4 % (95 % CI 45·7, 49·1 %) in preschool-aged children, 41·8 % (95 % CI 39·9, 43·8 %) in pregnant women and 30·2 % (95 % CI 28·7, 31·6 %) in non-pregnant women. In numbers, 293 million (95 % CI 282, 303 million) preschool-aged children, 56 million (95 % CI 54, 59 million) pregnant women and 468 million (95 % CI 446, 491 million) non-pregnant women are affected. Conclusion Anaemia affects one-quarter of the world's population and is concentrated in preschool-aged children and women, making it a global public health problem. Data on relative contributions of causal factors are lacking, however, which makes it difficult to effectively address the proble

Guiding structures with multiply connected cross-sections: evolution of propagation in external fields at complex Robin parameters

Properties of the two-dimensional ring and three-dimensional infinitely long straight hollow waveguide with unit width and inner radius $\rho_0$ in the superposition of the longitudinal uniform magnetic field $\bf B$ and Aharonov-Bohm flux are analyzed within the framework of the scalar Helmholtz equation under the assumption that the Robin boundary conditions at the inner and outer confining walls contain extrapolation lengths $\Lambda_{in}$ and $\Lambda_{out}$, respectively, with nonzero imaginary parts. It is shown that, compared to the disk geometry, the annulus opens up additional possibilities of varying magnetization and currents by tuning imaginary components of the Robin parameters on each confining circumference; in particular, the possibility of restoring a lossless longitudinal flux by zeroing imaginary part $E_i$ of the total transverse energy $E$ is discussed. The energy $E$ turns real under special correlation between the imaginary parts of $\Lambda_{in}$ and $\Lambda_{out}$ with the opposite signs what physically corresponds to the equal transverse fluxes through the inner and outer interfaces of the annulus. In the asymptotic case of the very large radius, simple expressions are derived and applied to the analysis of the dependence of the real energy $E$ on $\Lambda_{in}$ and $\Lambda_{out}$. New features also emerge in the magnetic field influence; for example, if, for the quantum disk, the imaginary energy $E_i$ is quenched by the strong intensities $B$, then for the annulus this takes place only when the inner Robin distance $\Lambda_{in}$ is real; otherwise, it almost quadratically depends on $B$ with the corresponding enhancement of the reactive scattering. Closely related problem of the hole in the otherwise uniform medium is also addressed for real and complex extrapolation lengths with the emphasis on the comparative analysis with its dot counterpart.Comment: 37 pages, 9 figure

Targeting of T/Tn Antigens with a Plant Lectin to Kill Human Leukemia Cells by Photochemotherapy

Photochemotherapy is used both for solid tumors and in extracorporeal treatment of various hematologic disorders. Nevertheless, its development in oncology remains limited, because of the low selectivity of photosensitizers (PS) towards human tumor cells. To enhance PS efficiency, we recently covalently linked a porphyrin (TrMPyP) to a plant lectin (Morniga G), known to recognize with high affinity tumor-associated T and Tn antigens. The conjugation allowed a quick uptake of PS by Tn-positive Jurkat leukemia cells and efficient PS-induced phototoxicity. The present study was performed: (i) to evaluate the targeting potential of the conjugate towards tumor and normal cells and its phototoxicity on various leukemia cells, (ii) to investigate the mechanism of conjugate-mediated cell death. The conjugate: (i) strongly increased (×1000) the PS phototoxicity towards leukemic Jurkat T cells through an O-glycan-dependent process; (ii) specifically purged tumor cells from a 1∶1 mixture of Jurkat leukemia (Tn-positive) and healthy (Tn-negative) lymphocytes, preserving the activation potential of healthy lymphocytes; (iii) was effective against various leukemic cell lines with distinct phenotypes, as well as fresh human primary acute and chronic lymphoid leukemia cells; (iv) induced mostly a caspase-independent cell death, which might be an advantage as tumor cells often resist caspase-dependent cell death. Altogether, the present observations suggest that conjugation with plant lectins can allow targeting of photosensitizers towards aberrant glycosylation of tumor cells, e.g. to purge leukemia cells from blood and to preserve the normal leukocytes in extracorporeal photochemotherapy

Conclusions of the Joint WHO/UNICEF/IAEA/IZiNCG Interagency Meeting on Zinc Status Indicators

Zinc deficiency is an important cause of morbidity in developing countries, particularly among young children, yet little information is available on the global prevalence of zinc deficiency. A working group meeting was convened by the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), the International Atomic Energy Agency (IAEA), and the International Zinc Nutrition Consultative Group (IZiNCG) to review methods of assessing population zinc status and provide standard recommendations for the use of specific biochemical, dietary, and functional indicators of zinc status in populations. The recommended biochemical indicator is the prevalence of serum zinc concentration less than the age/sex/time of day-specific cutoffs; when the prevalence is greater than 20%, intervention to improve zinc status is recommended. For dietary indicators, the prevalence (or probability) of zinc intakes below the appropriate estimated average requirement (EAR) should be used, as determined from quantitative dietary intake assessments. Where the prevalence of inadequate intakes of zinc is greater than 25%, the risk of zinc deficiency is considered to be elevated. Previous studies indicate that stunted children respond to zinc supplementation with increased growth. When the prevalence of low height-for-age is 20% or more, the prevalence of zinc deficiency may also be elevated. Ideally, all three types of indicators would be used together to obtain the best estimate of the risk of zinc deficiency in a population and to identify specific subgroups with elevated risk. These recommended indicators should be applied for national assessment of zinc status and to indicate the need for zinc interventions. The prevalence of low serum zinc and inadequate zinc intakes may be used to evaluate their impact on the target population’s zinc status.PRISI; IFPRI3; HarvestPlusHarvestPlu

Public Health Nutrition: Foreword

SCOPUS: cp.jinfo:eu-repo/semantics/publishe

Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005

Abstract Objective To provide current global and regional estimates of anaemia prevalence and number of persons affected in the total population and by population subgroup. Setting and design We used anaemia prevalence data from the WHO Vitamin and Mineral Nutrition Information System for 1993-2005 to generate anaemia prevalence estimates for countries with data representative at the national level or at the first administrative level that is below the national level. For countries without eligible data, we employed regression-based estimates, which used the UN Human Development Index (HDI) and other health indicators. We combined country estimates, weighted by their population, to estimate anaemia prevalence at the global level, by UN Regions and by category of human development. Results Survey data covered 48·8 % of the global population, 76·1 % of preschool-aged children, 69·0 % of pregnant women and 73·5 % of non-pregnant women. The estimated global anaemia prevalence is 24·8 % (95 % CI 22·9, 26·7 %), affecting 1·62 billion people (95 % CI 1·50, 1·74 billion). Estimated anaemia prevalence is 47·4 % (95 % CI 45·7, 49·1 %) in preschool-aged children, 41·8 % (95 % CI 39·9, 43·8 %) in pregnant women and 30·2 % (95 % CI 28·7, 31·6 %) in non-pregnant women. In numbers, 293 million (95 % CI 282, 303 million) preschool-aged children, 56 million (95 % CI 54, 59 million) pregnant women and 468 million (95 % CI 446, 491 million) non-pregnant women are affected. Conclusion Anaemia affects one-quarter of the world's population and is concentrated in preschool-aged children and women, making it a global public health problem. Data on relative contributions of causal factors are lacking, however, which makes it difficult to effectively address the proble